Suppr超能文献

Notch1 基因座的替代启动子使用支持 T 细胞发育和白血病发生中的配体非依赖性信号传导。

Alternative promoter usage at the Notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis.

机构信息

Vascular Biology and Inflammation Department, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid 28029, Spain.

出版信息

Immunity. 2010 Nov 24;33(5):685-98. doi: 10.1016/j.immuni.2010.11.008.

Abstract

Loss of the transcription factor Ikaros is correlated with Notch receptor activation in T cell acute lymphoblastic leukemia (T-ALL). However, the mechanism remains unknown. We identified promoters in Notch1 that drove the expression of Notch1 proteins in the absence of a ligand. Ikaros bound to both canonical and alternative Notch1 promoters and its loss increased permissive chromatin, facilitating recruitment of transcription regulators. At early stages of leukemogenesis, increased basal expression from the canonical and 5'-alternative promoters initiated a feedback loop, augmenting Notch1 signaling. Ikaros also repressed intragenic promoters for ligand-independent Notch1 proteins that are cryptic in wild-type cells, poised in preleukemic cells, and active in leukemic cells. Only ligand-independent Notch1 isoforms were required for Ikaros-mediated leukemogenesis. Notch1 alternative-promoter usage was observed during T cell development and T-ALL progression. Thus, a network of epigenetic and transcriptional regulators controls conventional and unconventional Notch signaling during normal development and leukemogenesis.

摘要

转录因子 Ikaros 的缺失与 T 细胞急性淋巴细胞白血病(T-ALL)中的 Notch 受体激活相关。然而,其机制尚不清楚。我们鉴定了 Notch1 中的启动子,这些启动子在没有配体的情况下驱动 Notch1 蛋白的表达。Ikaros 结合到经典和替代的 Notch1 启动子上,其缺失增加了允许性染色质,促进了转录调节剂的募集。在白血病发生的早期,来自经典和 5'-替代启动子的基础表达增加启动了一个反馈回路,增强了 Notch1 信号。Ikaros 还抑制了内源性启动子,这些启动子对于野生型细胞中的配体非依赖性 Notch1 蛋白是隐匿的,在白血病前细胞中处于预备状态,在白血病细胞中是活跃的。只有配体非依赖性 Notch1 异构体是 Ikaros 介导的白血病发生所必需的。在 T 细胞发育和 T-ALL 进展过程中观察到 Notch1 替代启动子的使用。因此,一组表观遗传和转录调节因子在正常发育和白血病发生过程中控制着传统和非常规的 Notch 信号。

相似文献

2
Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL.
Blood. 2010 Dec 16;116(25):5443-54. doi: 10.1182/blood-2010-05-286658. Epub 2010 Sep 9.
4
MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia.
Sci Signal. 2017 Nov 14;10(505):eaam6846. doi: 10.1126/scisignal.aam6846.
5
Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agents.
Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5106-11. doi: 10.1073/pnas.1001064107. Epub 2010 Mar 1.
6
Cooperation between somatic Ikaros and Notch1 mutations at the inception of T-ALL.
Leuk Res. 2011 Nov;35(11):1512-9. doi: 10.1016/j.leukres.2011.07.024. Epub 2011 Aug 15.
7
Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice.
Mol Cell Biol. 2006 Jan;26(1):209-20. doi: 10.1128/MCB.26.1.209-220.2006.
8
Monoallelic Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic Leukemia.
Front Immunol. 2022 Mar 24;13:867443. doi: 10.3389/fimmu.2022.867443. eCollection 2022.
9
Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia.
Leukemia. 2015 Jun;29(6):1301-11. doi: 10.1038/leu.2015.27. Epub 2015 Feb 6.

引用本文的文献

2
IKAROS: from chromatin organization to transcriptional elongation control.
Cell Death Differ. 2025 Jan;32(1):37-55. doi: 10.1038/s41418-023-01212-2. Epub 2023 Aug 24.
4
Notch gives early T cell progenitors time to grow up.
Nat Immunol. 2022 Nov;23(11):1523-1524. doi: 10.1038/s41590-022-01323-x.
5
Fine-tuning Notch1 by the stage-specific enhancer.
Nat Immunol. 2022 Nov;23(11):1509-1511. doi: 10.1038/s41590-022-01341-9.
7
TCFL5 deficiency impairs the pachytene to diplotene transition during spermatogenesis in the mouse.
Sci Rep. 2022 Jun 29;12(1):10956. doi: 10.1038/s41598-022-15167-w.
8
E Protein Transcription Factors as Suppressors of T Lymphocyte Acute Lymphoblastic Leukemia.
Front Immunol. 2022 Apr 20;13:885144. doi: 10.3389/fimmu.2022.885144. eCollection 2022.
9
Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in T Acute Lymphoblastic Leukemia.
Front Immunol. 2022 Mar 18;13:845488. doi: 10.3389/fimmu.2022.845488. eCollection 2022.

本文引用的文献

1
Awakening lineage potential by Ikaros-mediated transcriptional priming.
Curr Opin Immunol. 2010 Apr;22(2):154-60. doi: 10.1016/j.coi.2010.02.011. Epub 2010 Mar 17.
2
Histones: annotating chromatin.
Annu Rev Genet. 2009;43:559-99. doi: 10.1146/annurev.genet.032608.103928.
3
Metalloprotease ADAM10 is required for Notch1 site 2 cleavage.
J Biol Chem. 2009 Nov 6;284(45):31018-27. doi: 10.1074/jbc.M109.006775. Epub 2009 Sep 2.
4
Pre-TCR signaling inactivates Notch1 transcription by antagonizing E2A.
Genes Dev. 2009 Jul 15;23(14):1665-76. doi: 10.1101/gad.1793709.
5
Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells.
Immunity. 2009 Apr 17;30(4):493-507. doi: 10.1016/j.immuni.2009.01.014. Epub 2009 Apr 2.
6
The different faces of Notch in T-helper-cell differentiation.
Nat Rev Immunol. 2009 Feb;9(2):116-24. doi: 10.1038/nri2488.
7
Notch 1 keeps pro-T cells on track.
Immunity. 2009 Jan 16;30(1):5-7. doi: 10.1016/j.immuni.2008.12.008.
8
Acute lymphoblastic leukemia--on the wings of IKAROS.
N Engl J Med. 2009 Jan 29;360(5):524-6. doi: 10.1056/NEJMe0809819. Epub 2009 Jan 8.
9
Ikaros regulates Notch target gene expression in developing thymocytes.
J Immunol. 2008 Nov 1;181(9):6265-74. doi: 10.4049/jimmunol.181.9.6265.
10
Ikaros represses the transcriptional response to Notch signaling in T-cell development.
Mol Cell Biol. 2008 Dec;28(24):7465-75. doi: 10.1128/MCB.00715-08. Epub 2008 Oct 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验